ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

0FRI Quantel Sa

11.48
0.00 (0.00%)
24 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Quantel Sa LSE:0FRI London Ordinary Share FR0000038242 QUANTEL ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 11.48 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Electromedical Apparatus 207.91M 7.13M 0.3172 28.63 257.92M

LUMIBIRD: EXPLORATORY PROJECT TO SELL THE MEDICAL DIVISION

27/11/2024 7:00am

UK Regulatory


Quantel (LSE:0FRI)
Historical Stock Chart


From Dec 2024 to Dec 2024

Click Here for more Quantel Charts.
LUMIBIRD: EXPLORATORY PROJECT TO SELL THE MEDICAL DIVISION

Lannion, November 27, 2024 – 8:00 am

LUMIBIRD: EXPLORATORY PROJECT TO SELL THE MEDICAL DIVISION

Following market rumours, Lumibird (FR0000038242 - LBIRD) confirms that it is currently exploring the potential sale of its medical division.

Lumibird is at a very early stage of the process and there can be no certainty as to its outcome.

The Company will communicate in due course in accordance with applicable regulations.

LUMIBIRD is one of the world's leading laser specialists. With 50 years' experience and expertise in solid-state, diode and fibre laser technologies, the Group designs, manufactures and distributes high-performance laser solutions via two divisions: Photonics and Medical. The Photonics Division designs and produces components, lasers and systems for the defence and space, environment, topography and safety, industrial and scientific, and medtech markets. The Medical branch designs and produces medical diagnostic and treatment systems for ophthalmology.
The result of the merger in October 2017 between the Keopsys and Quantel Groups, LUMIBIRD, with more than 1,000 employees and over €203.6m in sales in 2023 is present in Europe, America and Asia.
LUMIBIRD shares are listed in compartment B of Euronext Paris. FR0000038242 - LBIRD        www.lumibird.com
LUMIBIRD has been a member of Euronext Tech Leaders since 2022.

   

Attachment

  • 241127_ LUMIBIRD_Reaction_Rumeur_EN

1 Year Quantel Chart

1 Year Quantel Chart

1 Month Quantel Chart

1 Month Quantel Chart

Your Recent History

Delayed Upgrade Clock